Travere Therapeutics (TVTX) stock rose after Novartis (NVS) posted data for a rival kidney disease drug, while Calliditas (CALT) drew buyout interest.
https://seekingalpha.com/news/4110827-travere-stock-gains-novartis-data-calliditas-buyout
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.